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Comparison of bronchoalveolar lavage fluid obtained from Mannheimia
haemolytica-inoculated calves with and without prior treatment with the
selectin inhibitor TBC1269
Abstract
Objectives—To determine effects of selectin inhibitor TBC1269 on neutrophil infiltration, and
neutrophilassociated injury during pneumonia induced byMannheimia haemolytica and concentration of
antimicrobial anionic peptide (AAP) in bronchoalveolar lavage fluid (BALF) as well as antimicrobial activity
of BALF from healthy (control) neonatal calves, neonatal calves with M haemolytica-induced pneumonia,
neonatal calves with prior treatment with TBC1269, and adult cattle.
Animals—Eighteen 1- to 3-day-old calves and 9 adult cattle.
Procedure—Calves were inoculated with M haemolyticaor pyrogen-free saline (0.14M NaCl) solution into
the right cranial lung lobe, and BALF was collected 2 or 6 hours after inoculation. Thirty minutes before and 2
hours after inoculation, 4 calves received TBC1269. The BALF collected from 9 adult cattle was used for
comparison of BALF AAP concentration and antimicrobial activity. Protein concentration and neutrophil
differential percentage and degeneration in BALF were determined. An ELISA and killing assay were used to
determine BALF AAP concentration and antimicrobial activity, respectively.
Results—Total protein concentration was significantly decreased in BALF from calves receiving TBC1269.
Similar concentrations of AAP were detected in BALF from all calves, which were 3-fold higher than those in
BALF from adult cattle. However, BALF from neonates had little or no anti-M haemolytica activity.
Conclusions and Clinical Relevance—These results suggest that TBC1269 decreases pulmonary tissue
injury in neonatal calves infected with M haemolytica. Although AAP is detectable in neonatal BALF at 3 times
the concentration detected in adult BALF, neonatal BALF lacks antimicrobial activity forM haemolytica.
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Mannheimia haemolytica is an important pathogen ofruminants, and it colonizes the tonsils and pharyn-
geal area of the respiratory tract of cattle.1,2 During trans-
port or other stresses, bacteria increase in number3,4 and
induce an acute inflammatory response in the lungs
characterized by dense infiltrates of neutrophils into
alveolar spaces and tissue damage.5-7 Release of sub-
stances such as elastase, myeloperoxidase, and oxidative
free radicals from neutrophils has been associated with
tissue damage8-10 and plays a role in the pathogenesis of
pneumonia attributable to M haemolytica.11,12 Additional
evidence of the importance of neutrophils in M
haemolytica-induced pneumonia was indicated in the
reduction of tissue damage and vascular leakage of pro-
tein by depletion of neutrophils.13-16 Neutrophil-mediat-
ed damage to the respiratory tract removes the protec-
tive barrier provided by endothelial cells and mucosal
epithelium,11-14,16 allowing access of bacteria and inflam-
matory mediators to the exposed capillaries, which
results in reduction of gaseous exchange. Such damage
also may impair innate host defense mechanisms,
including mucociliary clearance and production of
antimicrobial peptide (AMP).
In response to an infectious agent within alveolar,
bronchiolar, or bronchial spaces, neutrophils infiltrate
into these areas by moving from the bloodstream,
through the endothelium, and through the perivascu-
lar tissue and pulmonary parenchyma until they reach
the pulmonary spaces. Adhesion molecules expressed
by neutrophils and endothelial cells mediate neu-
trophil extravasation. Selectin adhesion molecules
mediate the initial relatively unstable tethering step of
neutrophil adherence to the vasculature by binding sia-
lyl LewisX and related oligosaccharide receptors. There
are 3 types of selectins: L-selectin, which is detectable
on neutrophils and other leukocytes and binds ligands
on endothelial cells,17 and E- and P-selectin, which are
expressed primarily by endothelial cells and bind lig-
ands on neutrophils.18-20 This initial selectin-ligand
binding initiates expression of β2-integrins on the sur-
face of neutrophils,21 which mediate a more stable
adherence to an endothelial intracellular adhesion
molecule (ICAM) in preparation for movement
through the endothelium and into tissues. Inhibition
of the initial selectin-mediated tethering of neutrophils
to endothelium may play a role in reduction of neu-
trophil infiltration into the lungs during acute M
haemolytica-induced pneumonia. 
Investigators have used TBC1269, a nonoligosac-
charide selectin antagonist, to competitively inhibit
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Objectives—To determine effects of selectin inhibitor
TBC1269 on neutrophil infiltration, and neutrophil-
associated injury during pneumonia induced by
Mannheimia haemolytica and concentration of antimi-
crobial anionic peptide (AAP) in bronchoalveolar
lavage fluid (BALF) as well as antimicrobial activity of
BALF from healthy (control) neonatal calves, neonatal
calves with M haemolytica-induced pneumonia,
neonatal calves with prior treatment with TBC1269,
and adult cattle.
Animals—Eighteen 1- to 3-day-old calves and 9 adult
cattle. 
Procedure—Calves were inoculated with M
haemolytica or pyrogen-free saline (0.14M NaCl) solu-
tion into the right cranial lung lobe, and BALF was col-
lected 2 or 6 hours after inoculation. Thirty minutes
before and 2 hours after inoculation, 4 calves received
TBC1269. The BALF collected from 9 adult cattle was
used for comparison of BALF AAP concentration and
antimicrobial activity. Protein concentration and neu-
trophil differential percentage and degeneration in
BALF were determined. An ELISA and killing assay
were used to determine BALF AAP concentration and
antimicrobial activity, respectively.
Results—Total protein concentration was significant-
ly decreased in BALF from calves receiving TBC1269.
Similar concentrations of AAP were detected in BALF
from all calves, which were 3-fold higher than those in
BALF from adult cattle. However, BALF from
neonates had little or no anti-M haemolytica activity.
Conclusions and Clinical Relevance—These results
suggest that TBC1269 decreases pulmonary tissue
injury in neonatal calves infected with M haemolytica.
Although AAP is detectable in neonatal BALF at 3
times the concentration detected in adult BALF,
neonatal BALF lacks antimicrobial activity for M
haemolytica. (Am J Vet Res 2001;62:665–672)
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binding of sialyl LewisX to selectins in vitro.22-25 This
mimetic has been used in vivo in clinical studies for use
in the treatment of humans with allergic asthma. It is
effective for preventing neutrophil-mediated reperfu-
sion injury in rat liver23 and in reducing the initial cel-
lular response to pulmonary antigen in a sheep model
of allergic bronchoconstriction.25 Inhibition of selectin-
mediated neutrophil infiltration may reduce neu-
trophil-mediated pulmonary damage, thereby main-
taining the epithelial barrier and its associated defenses. 
Antimicrobial peptides are substances that have
antibacterial, antifungal, and antiviral properties in
vitro and in vivo.26,27 Several families of AMP are pro-
duced in the lungs of cattle28-30 and are believed to have
an important role in the innate immune system for pro-
tection of the lungs from bacterial invaders. One AMP
in cattle is antimicrobial anionic peptide (AAP). This
peptide is smaller than most AMP, and its anionic prop-
erties differ from most AMP, which are cationic.31 It is
composed of consecutive aspartates and requires zinc
as a cofactor.31 Antimicrobial anionic peptide initially
was isolated from ovine surfactant. It also is evident in
human lung tissue and is detectable in high amounts in
bronchoalveolar lavage fluid (BALF) collected from
humans and sheep.31,32 Antimicrobial anionic peptide is
bactericidal against M haemolytica as well as other bac-
teria at a minimum inhibitory concentration compara-
ble to that of other AMP such as α- and β-defensins.31
Antimicrobial anionic peptide is believed to be a
cleaved fragment secondary to a larger proprotein pro-
duced in the lungs.31 In contrast to AAP, some bovine
epithelial β-defensins such as tracheal antimicrobial
peptide and lingual antimicrobial peptide usually are
not found in mucus and serous respiratory secretions.
Instead, those compounds are found within epithelial
cells and are locally secreted following their induc-
tion.30,33,34 To our knowledge, the concentration of AAP
in BALF of neonatal calves has not been assessed. 
The objectives of the study reported here were to
test the extent to which inhibition of neutrophil adher-
ence with TBC1269 would affect neutrophil infiltra-
tion into the BALF of neonatal calves inoculated with
M haemolytica as well as neutrophil-associated lung
injury and to discern whether AAP is detectable in
BALF of neonatal calves. 
Materials and Methods
Animals—Eighteen colostrum-deprived male neonatal
(1 to 3 days old) Holstein calves were purchased from a uni-
versity dairy farm and transported to laboratory animal facil-
ities at our institution. They were maintained in accordance
with guidelines approved by an institutional animal care and
use committee. Calves were monitored daily for general
health (appetite, attitude, respiratory effort and sounds, and
nasal discharge). Calves were excluded from the study if they
were febrile, coughed excessively, had abnormal hematologic
and serologic values, or had other signs of illness. 
Procedure—One to 3 days after arrival, blood was col-
lected from a jugular vein, and calves were assigned to
groups. Calves were anesthetized, and 12 were inoculated
with M haemolytica (1 X 108 colony forming units [CFU]/ml
in a 5-ml injection, as described elsewhere7,35,36), whereas 6
were inoculated with 5 ml of pyrogen-free saline (0.14M
NaCl) solution. Inoculations were performed into the
bronchus of the right cranial lung lobe, using fiberoptic bron-
choscopy. One group of calves inoculated with M haemolyti-
ca received TBC1269 (25 mg/kg of body weight, IV, 30 min-
utes before and 2 hours after bacterial inoculation).
Calves were euthanatized 2 or 6 hours after inoculation.
Calves were euthanatized by IV injection of an overdose of
sodium pentobarbital immediately prior to necropsy and col-
lection of BALF. To avoid hyperstatic congestion and poten-
tial vascular leakage in postmortem specimens, BALF was
collected from each calf within 5 to 15 minutes after it was
euthanatized. Each group was comprised as follows: saline-
inoculated (control) calves euthanatized 2 (n = 3) and 6 (3)
hours after inoculation; M haemolytica-inoculated calves
euthanatized 2 (4) and 6 (4) hours after inoculation; and M
haemolytica-inoculated TBC1269-treated calves (4) euthana-
tized 6 hours after inoculation.
Mannheimia haemolytica inoculum—Mannheimia
haemolytica L101 were grown overnight on blood agar, trans-
ferred to tryptose broth, and incubated for 1 to 3 hours at 37
C on a magnetic stirrer to achieve a culture containing
approximately 1 X 108 CFU/ml. The organisms were pelleted,
using centrifugation (5,900 X g for 5 minutes at 4 C), and
resuspended in 5 ml of pyrogen-free saline solution. An
aliquot of saline solution was adjusted to a transmittance
value of 78% at a setting of 600 nm in a spectrophotometera
by aseptically adding the bacterial suspension. One milliliter
of the inoculum was removed from the adjusted suspension
and serially diluted (1- to 10-fold) in saline solution. Then,
0.1 ml of each dilution was spread onto agar plates contain-
ing trypticase soy agar with 5% defibrinated sheep blood.
Plates were incubated overnight, and colonies then were
counted. The original solution routinely contained 1.3 to 2.5
X 108 CFU/ml.
Production of sialyl Lewisx nonoligosaccharide mimet-
ic (TBC1269)—The compound TBC1269, a synthetic sialyl
Lewisx nonoligosaccharide mimetic antagonist (1,6-Bis[3-(3-
carboxymethylphenyl)-4-(2-α-D-mannopyranosyl-
oxy)phenyl]hexane) was produced and provided in a powder
form.22,b The compound TBC1269 inhibits binding (by 50%)
of human L-, E-, and P-selectins at concentrations of 87, 105,
and 17 µM, respectively.25 This compound does not have
cytotoxic effects on neutrophils as documented by safety and
efficacy studies in rats and dogs.23 The required dose was pre-
pared in sterile pyrogen-free saline solution (pH 7.4).
Collection of samples—Blood samples were collected
from each calf before inoculation and at time of euthanasia
for CBC and fibrinogen determination. Because calves were
colostrum-deprived and, therefore, acutely susceptible to
infections, blood values obtained before inoculation were
assessed for indications of systemic disease. Only calves with
baseline results of CBC that were within reference ranges
were used for the study. Hematologic variables were com-
pared between samples obtained before and after inoculation
for all calves used in the study.
In all calves, BALF was collected from the right cranial
lung lobe during necropsy. This lobe was dissected from the
remainder of the lungs, and 50 ml of pyrogen-free saline
solution was delivered into the main bronchus via a nozzle-
tipped syringe. This fluid immediately was gently aspirated
back into the syringe, and the volume of fluid was measured.
For all samples obtained from neonates, a portion of BALF
was reserved for cytologic assessment, and a portion was cen-
trifuged to remove cellular debris. Supernatant was retained
and frozen (–70 C) until assessed, using Bradford analysis to
determine protein concentration, an ELISA to determine
concentration of AAP, and a killing assay to determine
antimicrobial activity. In addition, BALF was collected from 9
666 AJVR, Vol 62, No. 5, May 2001
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healthy adult (> 1 year old) cattle that did not have a previ-
ous history or clinical signs of respiratory tract disease. In
these cattle, BALF was collected from the right tracheal
bronchus during an anesthetic episode, similar to the proce-
dure described in sheep.37 For all samples obtained from
adult cattle, BALF was centrifuged to remove cellular debris.
Supernatant was retained and frozen (–70 C) until assessed,
using an ELISA to determine concentration of AAP and a
killing assay to determine antimicrobial activity.
Cytologic assessment of BALF—Bronchoalveolar lavage
fluid from each neonatal calf was assessed to determine
amount collected, degree of transparency, and color. A nucle-
ated cell count was performed, using an automated hematol-
ogy analyzer,c and the value was rounded to the nearest tenth.
Fluid protein content was estimated, using a refractometer,d
and pH was determined. A differential cell count and cytolog-
ic examination were performed on each sample (direct smear
and centrifuge preparations) after use of Wright stain, and
neutrophil degeneration was classified and graded (0, nonde-
generate; 1, slightly degenerate; 2, moderately degenerate; 3,
degenerate; 4, severely degenerate). Neutrophil morphology
was classified by use of a predetermined scoring system: 0,
nondegenerate neutrophils that contained clumped
basophilic chromatin and appeared similar to neutrophils in
other blood samples with only a slight allowance for nuclear
swelling attributable to washing; 1, slightly degenerate neu-
trophils that had intact but mildly dispersed chromatin with
mild nuclear swelling that altered the tinctorial property from
dark basophilic to dark eosinophilic; 2, moderately degener-
ate neutrophils that contained nuclei with a dispersed
eosinophilic chromatin pattern, and nuclei were swollen to
twice normal width but still retained a lobulated pattern; 3,
degenerate neutrophils that had a minimal chromatin pattern
with a smooth nuclear content, light eosinophilic staining,
and a nucleus swollen to fill three fourths of the cell with loss
of a lobulated pattern; 4, severely degenerate neutrophils that
often had a ruptured cell membrane and a smooth light
eosinophilic nucleus that was rounded with loss of the lobu-
lar pattern and lack of chromatin structure. Slides were ran-
domly batched and examined by the same investigator (CBA).
Unlike absolute number of neutrophils in blood samples,
absolute number of neutrophils in BALF is deceptive, because
the technique yields a crude estimate, and many cells can be
lysed in animals with severe inflammation. Because lysed cells
would yield a low absolute cell count even in the face of
severe inflammation, it was elected to use percentages for dif-
ferential neutrophil counts. To numerically describe neu-
trophil percentages and degeneration in BALF samples, a
score for BALF obtained from each calf was calculated by mul-
tiplying the percentage of neutrophils in the BALF by their
grade for degeneration. An increase in neutrophil scores indi-
cated an increase in neutrophil percentages, an increase in
degeneration of neutrophils, or both, in BALF.
Bradford analysis of BALF—Bronchoalveolar lavage fluid
from each neonatal calf was analyzed for protein content, using
the Bradford method. Briefly, we prepared 8 dilutions of bovine
serum albumin,e each of which was mixed with a constant
amount of Bradford reagent dyef (2 ml of a 20% concentration)
to provide solutions with final concentrations ranging from 0.1
to 1.0 mg/ml in a volume of 2.04 ml. These solutions were ana-
lyzed to create a standard curve, using a spectrophotometerg set
at 595 nm. For determination of protein concentration, 40 µl of
each BALF sample was added to 2 ml of 20% Bradford reagent
dye. This mixture was analyzed, and the resultant concentra-
tion compared with values for the standard curve.
Detection of AAP in BALF—Concentration of AAP was
determined in BALF obtained from each neonatal calf and
adult cow by use of an ELISA, as described elsewhere.32,38
Briefly, microtiter plate wellsh were incubated overnight at 26
C with 100 µl (1 mg/ml) of ELISA-negative surfactant (neg-
ative-control sample) and ELISA-negative surfactant contain-
ing dilutions of synthesized AAP (positive-control sample) as
well as 100 µl of BALF from each animal. Potential open
reactive sites in wells were filled by incubating with blocking
buffer (2 incubations for 30 minutes at 26 C). Wells were
incubated with mouse anti-AAP antibody, 1G9-1C2, at a con-
centration of 1.0 µg/µl for 1 hour at 26 C. Wells then were
washed twice with blocking buffer and incubated for 1 hour
at 26 C with secondary antibody (goat anti-mouse IgG con-
jugated to peroxidasei), washed 3 times with blocking buffer,
and incubated with developing reagentj for 5 minutes. Plates
were read, using a spectrophotometera set at 450 nm.
Antimicrobial activity of BALF supernatant—
Antimicrobial activity for M haemolytica serotype A1 was
determined for BALF obtained from each animal, using
methods described elsewhere.31,38,39 Briefly, M haemolytica
serotype A1 was grown in tryptose broth at 37 C for 3 hours,
pelleted by centrifugation (5,900 X g for 15 minutes at 4 C),
and resuspended in saline solution. The suspension was
adjusted, using a spectrophotometera set at 600 nm, to 78%
transmittance; this suspension contained 1 X 108 CFU/ml and
was diluted with saline solution to achieve a concentration of
103 CFU/ml. A dilution susceptibility test was used to obtain
the percentage of killed bacteria in BALF, compared with that
in the saline control solution. Percentage of killed bacteria
was determined by the following equation: (1 – [CFU in
BALF/CFU in saline control mixture]) X 100.
Statistical analysis—An ANOVAk was used initially to
determine significant differences among the 5 neonatal
groups for band neutrophils in blood samples, BALF neu-
trophil scores, and BALF protein concentrations. When over-
all differences were detected among groups, pairwise com-
parisons of groups were performed. An ANOVAk also was
used initially to determine significant differences among the
5 neonatal groups for BALF AAP concentrations and BALF
antimicrobial activities. Because overall differences were not
detected for those variables, t-tests were used for compar-
isons of the means for all neonatal calves with those for adult
cattle. A value of P < 0.05 was considered significant.
Results
Neonatal calves—In all neonatal calves, WBC, dif-
ferential counts, and fibrinogen concentrations differed
between samples collected before and after inocula-
tion. Changes were particularly evident in values for
calves from the M haemolytica-inoculated groups and
included decreased total leukocyte counts (including
neutrophils and lymphocytes; data not shown). The
number of band neutrophils was significantly higher in
calves 6 hours after inoculation with M haemolytica,
compared with values for calves from both control
groups (2 and 6 hours after inoculation with saline
solution) and for calves 2 hours after inoculation with
M haemolytica (Table 1). The number of band neu-
trophils in TBC1269-treated calves 6 hours after inoc-
ulation with M haemolytica was similar to the values
for calves from both control groups as well as for
TBC1269-untreated calves 6 hours after inoculation
with M haemolytica, and values were significantly (P =
0.03) higher, compared with values for calves 2 hours
after inoculation with M haemolytica. We did not detect
other notable alterations in blood values between
TBC1269-treated and -untreated calves.
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BALF neutrophil scores—Increased neutrophil
scores indicated an increase in BALF neutrophil per-
centages, an increase in degeneration of neutrophils, or
both. For all calves, the factor that had the most effect
on neutrophil score was the degree of degeneration,
rather than neutrophil percentage (Table 2).
Neutrophil percentage was similar among calves from
all groups. Bronchoalveolar lavage fluid from calves
from both control groups as well as calves 2 hours after
inoculation with M haemolytica had significantly lower
neutrophil scores, compared with scores for TBC1269-
treated and -untreated calves 6 hours after inoculation
with M haemolytica (Fig 1). Neutrophil scores for
calves 2 hours after inoculation with M haemolytica
were higher, but not significantly, than neutrophil
scores for both control groups. Neutrophil scores for
calves 6 hours after inoculation with M haemolytica
that were treated with TBC1269 were lower, but not
significantly (P = 0.11), than values for calves 6 hours
after inoculation with M haemolytica that were not
treated with TBC1269. 
BALF protein concentration—Protein concentra-
tion in BALF from calves of both control groups and
calves 2 hours after inoculation with M haemolytica
were significantly lower, compared with concentra-
tions for TBC1269-untreated calves 6 hours after inoc-
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Figure 1—Mean ± SE neutrophil scores in bronchoalveolar
lavage fluid (BALF) obtained from neonatal calves. Calves were
treated as follows: inoculated with 5 ml of pyrogen-free saline
(0.14M NaCl) solution (gray bar), inoculated with 5 ml of solution
that contained 1 X 108 colony forming units (CFU) of Mannheimia
haemolytica/ml (black bar), or treated with a selectin inhibitor
(TBC1269; 25 mg/kg of body weight, IV) 30 minutes before and
2 hours after being inoculated with 5 ml of solution that con-
tained 1 X 108 CFU of M haemolytica/ml (striped bar). a,b =
Values with different letters differ significantly (P < 0.05). 
Table 1—Mean ± SE number of band neutrophils in blood samples obtained from neonatal calves
before or after inoculation with Mannheimia haemolytica
2 hours after inoculation 6 hours after inoculation
( 103 cells/l) ( 103 cells/l)
Treatment Before After Change Before After Change
Saline solution 0.09 0.09 0.14  0.11 0.04  0.17* 0.03  0.03 0.11  0.11 0.07  0.13*
Mannheimia haemolytica 0.06  0.02 0.02  0.02 0.03  0.04*† 0.33  0.33 1.14  0.51 0.81  0.43*
Mannheimia haemolytica
 TBC1269 ND ND ND 0.22  0.15 0.75  0.22 0.53  0.20*
*Value is significantly (P  0.05) less than the value for 6 hours after inoculation with M haemolytica. †Value is significantly
(P  0.05) less than the value for 6 hours after inoculation of calves with M haemolytica that were treated with TBC1269.
Saline  Inoculated with 5 ml of pyrogen-free saline (0.14M NaCl) solution; n  3 at 2 hours and 3 at 6 hours. Mannheimia
haemolytica  Inoculated with 5 ml of solution that contained 1  108 colony forming units (CFU) of M haemolytica/ml; n 
4 at 2 hours and 4 at 6 hours. Mannheimia haemolytica  TBC1269  Treated with a selectin inhibitor (TBC1269; 25 mg/kg of
body weight, IV) 30 minutes before and 2 hours after being inoculated with 5 ml of solution that contained 1  108 CFU of M
haemolytica/ml; n  4. ND  Not determined.
Table 2 —Percentage of neutrophils, grade for neutrophil degeneration, and neutrophil scores for bron-
choalveolar lavage fluid (BALF) obtained from neonatal calves
Grade for neutrophil
Treatment Percentage of neutrophils degeneration* Score†
Saline solution
2 hours after inoculation 20 to 81 0 to 3 0 to 0.03
6 hours after inoculation 80 to 95 0 to 1 0 to 0.2
Mannheimia haemolytica
2 hours after inoculation 65 to 90 0.5 to 4 0 0.33 to 1.1
6 hours after inoculation 60 to 100 1.5 to 4 0 1.35 to 4
Mannheimia haemolytica  TBC1269
6 hours after inoculation 60 to 99 0 to 4                              1.3 to 2.7
Values represent ranges for all calves in each group. *Scale of 0 (nondegenerate) to 4 (severely degenerate). †Score was
calculated by multiplying percentage of neutrophils by grade for neutrophil degeneration. See Table 1 for remainder of key. 
Figure 2—Mean ± SE protein concentrations in BALF obtained
from neonatal calves. See Figure 1 for key.
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ulation with M haemolytica (Fig 2). In addition, protein
concentrations for TBC1269-treated calves 6 hours
after inoculation with M haemolytica were significantly
lower than for TBC1269-untreated calves. 
Concentration of AAP in BALF—Antimicrobial
anionic peptide was detected in BALF from all neona-
tal calves (mean ± SE, 0.32 ± 0.05 mM) and adult cat-
tle (0.11 ± 0.05 mM; Table 3). Values for neonates
were significantly (P = 0.02) higher than for adults;
however, we did not detect significant differences in
AAP concentrations among neonatal groups.
Antimicrobial activity of BALF supernatant—
With the exception of 2 calves (1 in each of 2 groups),
BALF from neonatal calves lacked detectable antimi-
crobial activity, whereas BALF from adult cattle had
substantial antimicrobial activity (Table 3). Percentage
killing of M haemolytica achieved by use of BALF from
adult cattle ranged from 32 to 84% (mean, 62.7 ±
5.8%). In contrast, percentage killing achieved by use
of BALF from neonates ranged from 0 to 29% (mean,
2.0 ± 1.6%). The percentage killing achieved by use of
BALF from adult cattle was significantly (P = 0.01)
higher than that for BALF from neonates, even though
neonatal BALF contained more AAP. 
Discussion
Values changed for blood samples from all groups
of neonatal calves after inoculation in a manner that
would be expected in animals undergoing stress or tis-
sue demand for WBC. These changes included
decreased total leukocyte counts, including neu-
trophils and lymphocytes, and an increased number of
band neutrophils. Many of these changes were not sig-
nificantly different until 6 hours after inoculation with
M haemolytica, which was attributed to the time lag
between initial pulmonary inoculation with M
haemolytica and the leukocyte response in the circula-
tion. Band neutrophil counts in blood samples of
calves obtained 2 hours after inoculation with M
haemolytica were decreased, compared with counts
before inoculation. This decrease did not differ signifi-
cantly from changes found in either group of control
calves (2 or 6 hours after inoculation with saline solu-
tion) but did differ significantly from changes in the
TBC1269-treated group. This reflects the lack of a
leukocyte response in the circulation by 2 hours after
inoculation with M haemolytica as well as variability in
leukocyte counts of neonates. We did not detect any
other significant differences in blood leukocyte counts
between the TBC1269-treated group and any other
group; therefore, differences in BALF neutrophil
counts between calves 6 hours after inoculation with M
haemolytica that were treated or not treated with
TBC1269 probably were attributable to alterations in
neutrophil activity in the pulmonary vasculature,
rather than the drug’s ability to inhibit leukocyte pro-
duction or to sequestration of leukocytes.
A high neutrophil score reflects a high neutrophil
percentage in the BALF, a high degree of neutrophilic
cellular degeneration and lysis, or both. All calves had
similar total percentages of neutrophils as a result of
the inflammatory response elicited by deposition of a
fluid substance (saline solution or M haemolytica)
within a bronchus. Absolute neutrophil counts in
BALF could not be accurately assessed, but, one of the
investigators (ZAR) determined by use of morphomet-
ric assessment that neutrophilic infiltration into pul-
monary spaces was significantly reduced in the lungs
of calves 6 hours after inoculation with M haemolytica
that were treated with TBC1269, compared with
results for samples obtained from calves that were not
treated with TBC1269. Similar decreases in neutrophil
infiltration have been documented with the use of
TBC1269 in BALF obtained from sheep as well as rat
liver.23,25
Despite the reduction in neutrophil infiltration,
differences in neutrophil scores among groups were
attributable largely to differences in degree of neu-
trophil degeneration. Bronchoalveolar lavage fluid that
contains an increased number of degenerate neu-
trophils is indicative of a more severe pulmonary
inflammatory response. Furthermore, this indicates a
greater number of lysed neutrophils that release neu-
trophilic enzymes, resulting in damage to pulmonary
tissue. In support of another study that documented
substantial inflammation in the lungs by 4 hours after
inoculation with M haemolytica,16 neutrophil scores in
BALF were significantly (P = 0.01) higher in samples
obtained from our calves 6 hours after inoculation with
M haemolytica that were not treated with TBC1269,
compared with samples obtained 2 hours after inocu-
lation. Neutrophil scores for calves 2 hours after inoc-
ulation with M haemolytica were not significantly dif-
ferent than values for either group of control calves,
again supporting the lack of substantial inflammation
AJVR, Vol 62, No. 5, May 2001 669
Table 3—Antimicrobial anionic protein (AAP) concentrations and minimum inhibitory concentrations
(MIC) in BALF obtained from neonatal calves and adult cows
AAP (mM) MIC (%)
2 hours after 6 hours after 2 hours after 6 hours after
Treatment inoculation inoculation inoculation inoculation
Calves (n  18)
Saline 0.32  0.17 0.37  0.26 9.7  9.7 0  0
Mannheimia haemolytica 0.36  0.05 0.35  0.1 1.8  1.8 0  0
Mannheimia haemolytica 
TBC1269 ND 0.20  0.06 ND 0  0
All calves 0.32  0.05a 2.0  1.6a
Cows (n  9) 0.11  0.05b 62.7  5.8b
Values reported are mean  SE. a,b  For each variable, values differ significantly (P  0.05) between BALF obtained from
adult and neonatal cattle. See Table 1 for remainder of key.
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by 2 hours after inoculation with M haemolytica. Lower
scores were seen in BALF obtained from calves 6 hours
after inoculation with M haemolytica that were treated
with TBC1269, but they were not significantly 
(P = 0.11) different, compared with scores of calves
that were not treated with TBC1269. This was largely
attributable to decreased degeneration of neutrophils
in calves given TBC1269. 
Neutrophil migration into the lungs during M
haemolytica-induced pneumonia may be beneficial or
deleterious. During pneumonia attributable to M
haemolytica, neutrophils are needed to reduce bacteri-
al viability, yet release of cellular lysosomal enzymes,
free radicals, and other factors contributes to tissue
damage.8-10 Protein leakage from vessels as a result of
pulmonary parenchymal and vascular compromise
(damage to the alveolar-capillary barrier) is a measure
of tissue damage.40,41 In the previously mentioned
study,16 a significant number of neutrophils migrated
into the lungs by 4 hours after inoculation with M
haemolytica, coincident with a significant increase in
protein concentrations in the BALF. In support of that
study, BALF protein concentrations reported here were
significantly (P = 0.003) higher 6 hours after inocula-
tion with M haemolytica from TBC1269-untreated
calves, compared with values 2 hours after inoculation.
Protein concentrations from calves 2 hours after inoc-
ulation with M haemolytica did not differ significantly
from values for either group of control calves, which
further supports a lack of substantial inflammation 2
hours after inoculation with M haemolytica.
Bronchoalveolar lavage fluid from calves 6 hours after
inoculation with M haemolytica that were treated with
TBC1269 had significantly (P = 0.02) lower concentra-
tions of protein, compared with concentrations in
BALF obtained from calves not treated with TBC1269.
This result supports results of studies in which there
was a decrease in tissue damage and vascular leakage of
protein following neutrophil depletion.13-16
These findings for protein concentration in BALF
reflect changes seen in neutrophil scores. Neutrophils
that are more degenerate are indicative of a more severe
inflammatory process, and this results in a release of
additional neutrophilic enzymes, causing additional pul-
monary tissue damage with breakdown of the alveolar
capillary barrier and protein leakage. Use of TBC1269
caused significantly (P = 0.02) lower protein concentra-
tions in BALF, compared with concentrations in BALF
from calves not treated with TBC1269, indicating less
pulmonary tissue injury in TBC1269-treated calves.
This indicates a lower degree of inflammatory response
in these calves that may be attributable to several mech-
anisms. First, TBC1269 inhibits selectin-mediated
adherence between neutrophils and endothelium, and
this may reduce the number of neutrophils that pass
through pulmonary vessels and enter pulmonary spaces.
Because we could not assess BALF absolute cell counts,
decreased infiltration of neutrophils into pulmonary
spaces could not be assessed, but it was seen during
morphometric assessment of these tissues (ZAR) and
has been reported with the use of TBC12689 in BALF
obtained from sheep25 as well as rat liver.23 Second,
TBC1269 may alter or reduce neutrophil activation
through inhibition of selectin-ligand binding. During
neutrophil infiltration into the lungs, selectin-ligand
binding activates neutrophils to express β2-integrins
that bind intracellular adhesion molecules (ICAM),
mediating vascular extravasation and tissue migration.21
Lack of activation may prevent optimal β2-integrin
expression, thus further interfering with neutrophilic
infiltration into pulmonary spaces. Third, neutrophil
activation is followed by metalloproteinase cleavage of
the L-selectin molecule at the point where the external
domain joins the transmembrane domain.42 The internal
cytoplasmic tail of L-selectin interacts with cytoskeletal
elements, including α-actinin.42 It is possible that
decreased selectin-ligand binding maintains the integri-
ty of the selectin molecule and its connection to
cytoskeletal elements. This may explain the lower
amount of neutrophilic degeneration in treated calves.
Fourth, M haemolytica leukotoxin may promote neu-
trophil apoptosis by binding to β2-integrin.43 Prevention
of selectin-ligand-mediated activation of β2-integrin
expression may prevent leukotoxin binding, providing
an indirect means for prevention of neutrophil apopto-
sis. Last, the kinetics of TBC1269 have not been fully
explored in cattle, which is attributable to the fact that it
is an experimental compound. However, in 1 study,
TBC1269 administered once (3 mg/kg, IV) caused
reduced neutrophil infiltration in sheep.25 Although the
dosage used in the study reported here was considered
extremely high, and the dosing time was considered rep-
etitious, there is the possibility that the compound is not
effective by 6 hours after administration. In that case,
the low number of mildly degenerate cells in BALF from
TBC1269-treated calves may have migrated from the
vasculature into the airways only a short time before
BALF was harvested and would, at a later time point,
resemble those in the untreated calves. Thus, barring
erroneous interpretation due to inadequate dosing of
TBC1269, selectin inhibition of nuetrophils appears to
prevent a portion of the nuetrophil-mediated damage to
the pulmonary tissues, thereby maintaining the protec-
tive pulmonary epithelial barrier and preserving epithe-
lial defense mechanisms.
Experimental depletion of neutrophils during M
haemolytica-induced pneumonia results in a reduction
in tissue damage and vascular leakage of protein.13-16
However, M haemolytica can induce pulmonary tissue
damage independent of neutrophils. Mannheimia
haemolytica endotoxin (lipopolysaccharide) can have
cytotoxic effects on endothelial cells and can produce
pulmonary lesions.5,44,45 Also, M haemolytica has addi-
tional products, such as leukotoxin and capsular poly-
saccharide, capable of producing tissue damage.5,37,45,46
Thus, complete neutrophil depletion is not a viable
therapeutic alternative for calves with pneumonia
attributable to M haemolytica in terms of practicality or
in effectiveness at clearing infection and preventing
related tissue damage. Selectin inhibition may provide
a means to decrease but not completely block neu-
trophil infiltration from the vasculature into the pul-
monary spaces in response to infection with M
haemolytica. Some degree of neutrophil infiltration into
pulmonary spaces through thin alveolar walls probably
is retained following TBC1269 administration. 
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Large amounts of AAP are detectable in BALF from
humans and sheep31,32; however, to our knowledge, this
is the first report of the detection of AAP in BALF from
neonatal calves. Antimicrobial anionic peptide was evi-
dent at similar concentrations in the BALF from calves
of all groups. Significant differences were not detected
in concentrations from control calves, calves that had
been inoculated with M haemolytica, or calves that had
been inoculated with M haemolytica and treated with
TBC1269. Mean AAP concentration in BALF obtained
from all neonatal calves was approximately 3-fold
higher than the mean AAP concentration in BALF
obtained from adult cattle. 
Even though mean AAP concentration in BALF
from adult cattle was approximately a third of the
mean concentration in BALF from neonates, BALF
from neonates containing this peptide had significant-
ly less antimicrobial activity against M haemolytica,
compared with the activity of BALF from adults.
Antimicrobial activity was discernible in BALF from
only 2 calves. Values for these 2 calves may have rep-
resented sample error, or there may have been antimi-
crobial activity attributable to AAP or an alternative
antimicrobial substance in these young animals. It is
believed that AAP is a propeptide that is cleaved from
a larger peptide.31 Thus, it is possible that the larger
peptide is not being effectively produced or metabo-
lized in neonatal calves, and, therefore, neonatal calves
lack antimicrobial activity. Also, antimicrobial peptides
work in concert with other compounds and substances
in vivo to kill microbes effectively.47 It is possible that
unknown cofactors or copeptides necessary for full
antimicrobial activity of AAP may not exist or may not
be effective in neonatal animals.
Although AAP is microcidal alone or in concert
with surfactant,31 surfactant proteins and other mole-
cules in BALF also are microcidal48 and may result in
the antimicrobial activity detected in BALF from adult
and neonatal cattle. Thus, although it is possible that
the differences in antimicrobial activity between adults
and neonates seen in this study were related to the
function of AAP or its regulators, the effectiveness of
AAP alone in bovine BALF cannot be assessed in our
study. Additional investigations are needed to directly
assess antimicrobial activity of AAP in bovine BALF.
In neonates, M haemolytica-induced pneumonia
does not appear to reduce the concentration of AAP in
BALF. Perhaps AAP simply was not being consumed in
fighting the infection, because it was not antimicro-
bially active at that time. This also could explain the
lower basal concentrations of AAP in BALF of adult
cattle, compared with values for BALF of neonates.
Antimicrobial peptides function in response to micro-
bial infection, but they also prevent initial coloniza-
tion.49 Antimicrobial anionic peptide may be continual-
ly consumed in adult animals in a prophylactic man-
ner, whereas BALF concentrations in neonates remain
high, because the peptide lacks function. This lack of
AAP activity may help explain the sensitivity of
neonates to pulmonary colonization with infectious
organisms such as M haemolytica.
Selectin inhibition resulted in decreased neu-
trophil-mediated damage to pulmonary tissues, as evi-
denced by decreased vascular leakage of protein into
BALF in TBC1269-treated calves 6 hours after inocu-
lation with M haemolytica. Thus, TBC1269 may be an
effective therapeutic tool for pulmonary infections
such as M haemolytica-induced pneumonia, because
neutrophils retain their ability to infiltrate pulmonary
spaces, although fewer infiltrate. Neutrophils are nec-
essary to combat infection, so a drug that only partial-
ly blocks neutrophilic infiltration into pulmonary
spaces may be effective in allowing some neutrophils
into these areas while concurrently limiting their
number to prevent excessive neutrophil-mediated tis-
sue damage. Additional studies could include evalua-
tion of the use of TBC1269 in conjunction with an
antibiotic in the treatment of calves with acute pneu-
monia attributable to M haemolytica to determine
whether a beneficial synergistic effect exists between
the compound and an antibiotic. In addition,
TBC1269 is effective in preventing neutrophil-mediat-
ed reperfusion injury in rat liver23 and in reducing the
initial cellular response to pulmonary antigen in a
sheep model of allergic bronchoconstriction.25 Thus,
TBC1269 may be effective in the treatment of multiple
species of animals with several types of inflammatory
disorders.
Neonatal calves appear to lack a mature effective
antimicrobial peptide response, as evidenced by the
decreased bactericidal activity of BALF obtained from
neonates, compared with activity of BALF obtained
from adult cattle, despite a concentration of AAP in
neonatal BALF at 3 times the concentration found in
BALF of adult cattle. We believe that this may be a rea-
son for the susceptibly of neonatal calves to pulmonary
infections. The potential role of AAP in the prevention
and treatment of naturally acquired disease requires
additional investigation. 
aColeman model 35, Bacharach Instrument Co, Pittsburgh, Pa.
bTBC1269, Texas Biotechnology Corp, Houston, Tex.
cCell-Dyne, Abbott Diagnostics, Santa Clara, Calif.
dVeterinary refractometer, Reichert Scientific Instruments, Buffalo, NY.
eAlbumin, Bovine, Sigma Chemical Co, St Louis, Mo.
fBio-Rad protein assay kit #1, Bio-Rad Labs, Hercules, Calif.
gMilton Roy Spectronic 3000 array, Spectronic Instruments Inc,
Gallaway, Ohio.
hImmulon 1B plates, Dynex Technologies Inc, Chantilly, Va.
iPeroxidase labeled affinity purified antibody to mouse IgG (H + L),
Kirkegaard & Perry, Gaithersburg, Md.
jTMB Microwell peroxidase substrate, Kirkegaard & Perry,
Gaithersburg, Md.
kSAS, version 6.12, SAS Institute, Cary, NC.
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